Lexicon Pharmaceuticals (LXRX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

LXRX is expected to report earnings to fall 14.28% to -15 cents per share on March 12

Lexicon Pharmaceuticals LXRX Stock Earnings Reports

Q4'24

Est.

$-0.15

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.20

Q4'23

Beat

by $0.02

The last earnings report on November 12 showed earnings per share of -18 cents, missing the estimate of -15 cents. With 2.48M shares outstanding, the current market capitalization sits at 383.18M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2445 Technology Forest Boulevard

Phone

+1 281 863-3000

Employees

285

Web

https://www.lexpharma.com